Synovus Financial Corp Genmab A/S Transaction History

Synovus Financial Corp

$8.56 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$26.43 - $32.77 $111,085 - $137,732	4,203 Added 5.34%	82,858 $2.48 Million
Q3 2023 Nov 13, 2023	BUY	$35.27 - $42.24 $86,376 - $103,445	2,449 Added 3.21%	78,655 $2.77 Million
Q2 2023 Aug 08, 2023	SELL	$37.4 - $42.94 $169,796 - $194,947	-4,540 Reduced 5.62%	76,206 $2.9 Million
Q1 2023 May 11, 2023	SELL	$34.88 - $43.22 $482,285 - $597,602	-13,827 Reduced 14.62%	80,746 $3.05 Million
Q4 2022 Feb 06, 2023	BUY	$33.8 - $47.06 $33,698 - $46,918	997 Added 1.07%	94,573 $4.01 Million
Q3 2022 Oct 27, 2022	SELL	$31.52 - $373.61 $18,060 - $214,078	-573 Reduced 0.61%	93,576 $3.01 Million
Q2 2022 Aug 10, 2022	BUY	$26.83 - $38.57 $26,454 - $38,030	986 Added 1.06%	94,149 $3.06 Million
Q1 2022 May 12, 2022	BUY	$30.95 - $39.68 $261,094 - $334,740	8,436 Added 9.96%	93,163 $3.37 Million
Q4 2021 Feb 14, 2022	BUY	$35.87 - $47.12 $183,403 - $240,924	5,113 Added 6.42%	84,727 $3.35 Million
Q3 2021 Nov 08, 2021	SELL	$41.55 - $48.72 $1.51 Million - $1.77 Million	-36,244 Reduced 31.28%	79,614 $3.48 Million
Q2 2021 Aug 11, 2021	BUY	$32.88 - $44.57 $46,459 - $62,977	1,413 Added 1.23%	115,858 $4.72 Million
Q1 2021 May 11, 2021	BUY	$30.92 - $44.4 $565,928 - $812,653	18,303 Added 19.04%	114,445 $3.76 Million
Q4 2020 Feb 11, 2021	BUY	$33.66 - $40.76 $157,495 - $190,716	4,679 Added 5.12%	96,142 $3.91 Million
Q3 2020 Nov 09, 2020	SELL	$33.07 - $38.68 $114,719 - $134,180	-3,469 Reduced 3.65%	91,463 $3.35 Million
Q2 2020 Aug 10, 2020	SELL	$20.05 - $33.89 $80,841 - $136,644	-4,032 Reduced 4.07%	94,932 $3.22 Million
Q1 2020 Apr 24, 2020	BUY	$17.15 - $25.22 $47,042 - $69,178	2,743 Added 2.85%	98,964 $2.1 Million
Q4 2019 Feb 06, 2020	SELL	$18.88 - $24.14 $862,740 - $1.1 Million	-45,696 Reduced 32.2%	96,221 $2.15 Million
Q3 2019 Nov 01, 2019	BUY	$18.0 - $21.38 $2.55 Million - $3.03 Million	141,917 New	141,917 $2.88 Million

Others Institutions Holding GMAB

# of Institutions

240

Shares Held

52.6M

Call Options Held

10.2K

Put Options Held

25.5K

Alliancebernstein L.P. New York, NY

15.1M
Shares

$336 Million
0.13% of portfolio
Black Rock Inc. New York, NY

5.08M
Shares

$113 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

4.42M
Shares

$98.1 Million
0.02% of portfolio
Harding Loevner LP Bridgewater, NJ

3.07M
Shares

$68 Million
0.44% of portfolio
Wellington Management Group LLP Boston, MA

2.31M
Shares

$51.2 Million
0.01% of portfolio

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $14.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.

Account